CBLL
Price
$27.40
Change
+$0.26 (+0.96%)
Updated
Oct 22 closing price
Capitalization
1.05B
11 days until earnings call
Intraday BUY SELL Signals
IART
Price
$12.32
Change
+$0.48 (+4.05%)
Updated
Oct 22 closing price
Capitalization
958.55M
131 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CBLL vs IART

CBLL vs IART Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CBLL vs. IART commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBLL is a StrongBuy and IART is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CBLL with price predictions
Oct 22, 2026

CBLL's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CBLL turned positive on October 13, 2026. Looking at past instances where CBLL's MACD turned positive, the stock continued to rise in 10 of 10 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on CBLL as a result. In 23 of 27 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

Following a +10.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBLL advanced for three days, in 95 of 111 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 40 of 54 cases where CBLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for CBLL moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In 10 of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBLL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

CBLL broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.198) is normal, around the industry mean (2.874). P/E Ratio (-15.568) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (9.009) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CBLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBLL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for IART with price predictions
Oct 22, 2026

IART in -11.97% downward trend, sliding for three consecutive days on October 21, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IART declined for three days, in 233 of 299 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IART as a result. In 74 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for IART turned negative on October 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

The Aroon Indicator for IART entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IART's RSI Oscillator exited the oversold zone, 28 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +4.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where IART advanced for three days, in 181 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

IART may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.919) is normal, around the industry mean (2.874). IART has a moderately low P/E Ratio (-136.944) as compared to the industry average of (2.324). Projected Growth (PEG Ratio) (0.669) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.751) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. IART’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IART’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
IART: Fundamental Ratings
IART
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CBLLIART
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 11 days ago
62%
Declines
ODDS (%)
Bearish Trend 15 days ago
77%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
70%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CBLL: $27.40 vs. IART: $12.32)
Brand notoriety: CBLL and IART are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CBLL: 91% vs. IART: 134%
Market capitalization -- CBLL: $1.05B vs. IART: $958.55M
CBLL [@Medical/Nursing Services] is valued at $1.05B. IART’s [@Medical/Nursing Services] market capitalization is $958.55M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $177.38B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBLL’s FA Score shows that 1 FA rating(s) are green while IART’s FA Score has 2 green FA rating(s).

  • CBLL’s FA Score: 1 green, 4 red.
  • IART’s FA Score: 2 green, 3 red.
According to our system of comparison, IART is a better buy in the long-term than CBLL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBLL’s TA Score shows that 4 TA indicator(s) are bullish while IART’s TA Score has 4 bullish TA indicator(s).

  • CBLL’s TA Score: 4 bullish, 4 bearish.
  • IART’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CBLL and IART are a good buy in the short-term.

Price Growth

CBLL (@Medical/Nursing Services) experienced а -0.87% price change this week, while IART (@Medical/Nursing Services) price change was -8.91% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.

Reported Earning Dates

CBLL is expected to report earnings on Nov 03, 2026.

IART is expected to report earnings on Mar 03, 2027.

Industries' Descriptions

@Medical/Nursing Services (-1.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
CBLL
Daily Signal:
Gain/Loss:
IART
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CBLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBLL has been loosely correlated with NPCE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CBLL jumps, then NPCE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBLL
1D Price
Change %
CBLL100%
+0.96%
NPCE - CBLL
39%
Loosely correlated
+0.69%
BFLY - CBLL
37%
Loosely correlated
-4.08%
SGHT - CBLL
36%
Loosely correlated
+4.48%
KIDS - CBLL
35%
Loosely correlated
+3.65%
IART - CBLL
33%
Loosely correlated
+4.10%
More

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+4.10%
RVTY - IART
49%
Loosely correlated
+0.48%
CNMD - IART
48%
Loosely correlated
+4.95%
MTD - IART
44%
Loosely correlated
+0.40%
A - IART
43%
Loosely correlated
-2.17%
AZTA - IART
43%
Loosely correlated
-2.04%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLIBA21.141.27
+6.39%
GCI Liberty Inc
CBOE327.728.90
+2.79%
Cboe Global Markets
SPHR111.61-2.46
-2.16%
Sphere Entertainment Co
IVVD0.61-0.03
-4.57%
Invivyd
DARE0.65-0.04
-5.28%
Dare Bioscience Inc.